Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
60 Degrees Pharmaceuticals Inc. (SXTP) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.41M |
|
$-7.37M |
|
$0.78M |
|
$0.63M |
|
$9.17M |
|
$-7.76M |
|
$0.39M |
|
$-7.37M |
|
$-7.37M |
|
$-7.37M |
|
$-7.37M |
|
$-7.37M |
|
$-7.37M |
|
$-7.76M |
|
$-7.50M |
|
0.67M |
|
0.67M |
|
$-11.73 |
|
$-11.73 |
|
| Balance Sheet Financials | |
$4.90M |
|
$0.25M |
|
$0.47M |
|
$5.37M |
|
$1.84M |
|
-- |
|
$0.14M |
|
$1.99M |
|
$-6.19M |
|
$3.16M |
|
$3.38M |
|
1.16M |
|
| Cash Flow Statement Financials | |
$-6.85M |
|
$0.25M |
|
$6.44M |
|
$1.66M |
|
$1.51M |
|
$-0.15M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
44.52% |
|
-550.61% |
|
-550.61% |
|
-532.20% |
|
-522.91% |
|
-522.69% |
|
$-7.04M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
1.19 |
|
2.76 |
|
132.01 |
|
119.07% |
|
-233.54% |
|
-137.31% |
|
-218.04% |
|
$2.91 |
|
$-10.51 |
|
$-10.22 |
|